Nipah (NiV) and Hendra (HeV) viruses are the deadliest human pathogens within the Paramyxoviridae family, which include human and animal pathogens of global biomedical importance. NiV and HeV are zoonotic viruses that can be transmitted directly to humans or intermediate amplifying hosts from their natural reservoirs in fruit bats. NiV and HeV infections cause respiratory and encephalitic illnesses, and NiV's mortality rate in humans can exceed 70 percent. Thus, NiV and HeV are the only paramyxoviruses classified BSL4 pathogens due to their extreme pathogenicity and lack of licensed vaccines or effective therapeutics. Paramyxoviruses are negative-sense RNA viruses that replicate in the cytoplasm. Their matrix structural protein organizes virion assembly at the plasma membrane and mediates viral budding from the cell surface. Curiously, the matrix protein of several paramyxoviruses has been observed to traffic in and out of the nucleus, although the functional relevance of paramyxovirus M proteins entering the nucleus has been unclear. We also found that NiV-M shuttles between the cytoplasmic and the nuclear compartments. However, our investigations established that proper nuclear-cytoplasmic trafficking of NiV-M, regulated by the ubiquitin-proteasome system, is critical for its functional localization to the plasma membrane, and its subsequent ability to mediate viral budding. Further study revealed a trove of NiV-M-interacting partners that places NiV-M at the nexus of multiple cell biological processes that are of contemporary scientific interest, including the cros regulation between the SUMO and ubiquitin-proteasome system in modulating subnuclear trafficking, and the function of PML bodies, nuclear structures involved in cellular antiviral defense. The goal of this application is to determine the role of SUMO and ubiquitin modifications in Nipah virus matrix trafficking and function. Understanding the basic cell biology of NiV-M will not only shed light on the properties that contribute to the unusually high virulence of this virus, but might also reveal host-pathogen interactions that have broader implications for viral pathogenesis in general. To understand the biological implications of NiV-M's complex intracellular sojourn, we propose the following three specific aims: (1) Identify and characterize post-translational modifications of NiV-M, focusing on the SUMO- and ubiquitin-proteasome pathway, and (2) define the functional roles for matrix post-translational modification in relation to viral pathogenesis.

Public Health Relevance

Paramyxoviruses include human and animal pathogens of global biomedical importance. Nipah virus (NiV) is an emerging paramyxovirus that is classified as a BSL4 select agent due to its extreme pathogenicity and lack of effective licensed therapeutics or vaccines. Understanding the basic cell biology of how NiV buds will reveal new therapeutic targets and host-pathogen interactions that have broader implications for viral pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI100498-02
Application #
8609476
Study Section
Special Emphasis Panel (ZRG1-F13-C (20))
Program Officer
Cassetti, Cristina
Project Start
2013-02-01
Project End
2015-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
2
Fiscal Year
2014
Total Cost
$55,670
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095